Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Objectives: Breast cancer (BC) stands as the second-leading cause of female-specific cancer-related fatalities globally, necessitating comprehensive research to address its critical aspects. This study aimed to explore the time intervals between surgery and disease recurrence in BC patients and their survival utilizing various parametric and semi-parametric models. Methods: After the examination of data collected from 2010 to 2021 at a BC Center in Tehran, Iran, 171 cases met the criteria for analysis out of 2246 datasets. Model fitting, was assessed through the Akaike Information Criterion (AIC), and indicated the logistic distribution as the most fit one among concurrent and independent variable models. Results: The Cox proportional hazard regression model consistently demonstrated superior fitting, characterized by the lowest AIC values. The average age at diagnosis was 50.39 years, with a standard deviation of 11.13. Typical survival time was estimated 53.44 months, falling within a confidence interval of 51.41–55.48 months at a 95% confidence level. The 1-year survival rate was determined at 0.92 (95% CI: 0.89–0.94). Notably, patient age while cancer diagnosis, progesterone receptor (PR), tumor grade, and tumor stage were found to be statistically significant ( P < .05) risk factors for prediction of BC recurrence after surgery in Iran by Cox model. Conclusions: Our findings underscore the importance of further exploration and consideration of the identified risk factors in BC research and treatment strategies.
Objectives: Breast cancer (BC) stands as the second-leading cause of female-specific cancer-related fatalities globally, necessitating comprehensive research to address its critical aspects. This study aimed to explore the time intervals between surgery and disease recurrence in BC patients and their survival utilizing various parametric and semi-parametric models. Methods: After the examination of data collected from 2010 to 2021 at a BC Center in Tehran, Iran, 171 cases met the criteria for analysis out of 2246 datasets. Model fitting, was assessed through the Akaike Information Criterion (AIC), and indicated the logistic distribution as the most fit one among concurrent and independent variable models. Results: The Cox proportional hazard regression model consistently demonstrated superior fitting, characterized by the lowest AIC values. The average age at diagnosis was 50.39 years, with a standard deviation of 11.13. Typical survival time was estimated 53.44 months, falling within a confidence interval of 51.41–55.48 months at a 95% confidence level. The 1-year survival rate was determined at 0.92 (95% CI: 0.89–0.94). Notably, patient age while cancer diagnosis, progesterone receptor (PR), tumor grade, and tumor stage were found to be statistically significant ( P < .05) risk factors for prediction of BC recurrence after surgery in Iran by Cox model. Conclusions: Our findings underscore the importance of further exploration and consideration of the identified risk factors in BC research and treatment strategies.
The accurate detection and quantification of quercetin dihydrate (QRC) are vital for quality control, pharmacokinetic studies, and bioavailability assessments in pharmaceutical and biological samples. This study aimed to develop and validate a cloud point extraction (CPE) method combined with spectrophotometry for the sensitive and environmentally friendly detection and quantification of QRC in pharmaceutical formulations and spiked urine samples. Methods. The CPE method employed Triton X-114 as a non-ionic surfactant to extract QRC from samples. The extraction process was optimized by evaluating key parameters, including surfactant concentration, incubation temperature, extraction time, and centrifugation speed. Spectrophotometric analysis was conducted before and after extraction to assess the sensitivity and linearity of the method. The method was validated using spiked urine samples and pharmaceutical formulations of QRC, with recovery rates, limits of detection (LOD), and linearity evaluated to ensure accuracy and precision. Results. The optimized CPE conditions included an incubation temperature of 65°C, a 5-minute extraction time, and centrifugation at 3500 rpm. The CPE method significantly improved the sensitivity of QRC detection, reducing the LOD from 0.0351 μg/mL (without CPE) to 0.0234 μg/mL (with CPE). The method exhibited excellent linearity (r² > 0.998) over a wide concentration range (1–12 μg/mL). High recovery rates (98.88% to 101.6%) and low relative standard deviations (RSD < 2%) were observed in pharmaceutical formulations and spiked urine samples, demonstrating the method’s accuracy and precision. The enrichment factor was 1.75, and the preconcentration factor was 4.6. Conclusions. The proposed CPE method combined with spectrophotometry provides a simple, sensitive, and environmentally friendly approach for QRC analysis. It offers significant advantages over conventional methods, including reduced organic solvent use and waste generation, making it suitable for routine analysis in pharmaceutical quality control and pharmacokinetic studies. The method’s adaptability to complex matrices, such as urine, and its potential for broader applications, including the analysis of other polyphenolic compounds, were also demonstrated.
Background: In the recent studies, the relationship between the magnesium and asthma has been more considered; hence, the present research has aimed to study this issue. Methodology: The study is a Randomized double blind placebo control trial, which has been conducted on the asthmatic patients who have been divided into two groups: group one consisting of those who have taken placebo and group two including those who have taken magnesium supplement. In the beginning and during the weeks 4, 8 and 12, FVC, FEV1, FEV1/FVC and ACT score have been measured. Results: 40 patients have been studied in two equal groups. The improvement rate of FEV1/FVC has been gradually increased in group2 and was significantly higher than group1 in the week 12. It was also higher in week 4 but not significantly. Moreover, according to FVC ratio, in weeks 4 and 12, the cure rate of the group2 was not significantly higher; however, it was significantly higher in the 8th week. The ACT score of group2 has also significantly increased in comparison to it in 4 weeks before the beginning of the study. Conclusion: It seems that the magnesium supplement is helpful in improving the clinical and spirometric measurements of asthmatic patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.